BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, Tanaka S, Yoshihara M. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther. 2003;18:245-252. [PMID: 12869086 DOI: 10.1046/j.1365-2036.2003.01669.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study. J Gastroenterol Hepatol. 2005;20:1661-1666. [PMID: 16246182 DOI: 10.1111/j.1440-1746.2005.04051.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kim MH, Kim HS, Park SY, Park CH, Choi SK, Rew JS. Analysis of Antimicrobial Resistance of Helicobacter pylori in Gwangju, Chonnam Provinces. Korean J Helicobacter Up Gastrointest Res 2012;12:82. [DOI: 10.7704/kjhugr.2012.12.2.82] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Shiota S, Murakami K, Fujioka T, Yamaoka Y. Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol. 2010;4:149-156. [PMID: 20350262 DOI: 10.1586/egh.10.7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lauwers GY, Srivastava A. Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am. 2007;36:813-829, vi. [PMID: 17996792 DOI: 10.1016/j.gtc.2007.08.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
6 Kuipers EJ, Malfertheiner P. Helicobacter pylori and Nonmalignant Diseases. Helicobacter 2004;9:29-34. [DOI: 10.1111/j.1083-4389.2004.00247.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: A systematic review and meta-analysis. World J Gastroenterol 2014; 20(19): 5903-5911 [PMID: 24914352 DOI: 10.3748/wjg.v20.i19.5903] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
8 Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;:CD002096. [PMID: 16625554 DOI: 10.1002/14651858.CD002096.pub4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
9 Kuipers EJ, Sipponen P. Helicobacter pylori eradication for the prevention of gastric cancer. Helicobacter. 2006;11 Suppl 1:52-57. [PMID: 16925613 DOI: 10.1111/j.1478-405X.2006.00425.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808-1825. [PMID: 17608775 DOI: 10.1111/j.1572-0241.2007.01393.x] [Cited by in Crossref: 769] [Cited by in F6Publishing: 682] [Article Influence: 51.3] [Reference Citation Analysis]
11 Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther 2005;21:1231-9. [PMID: 15882244 DOI: 10.1111/j.1365-2036.2005.02461.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
12 de Vries AC, Haringsma J, Kuipers EJ. The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection. Helicobacter 2007;12. [DOI: 10.1111/j.1523-5378.2007.00475.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
13 Park JY, Forman D, Greenberg ER, Herrero R. Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep. 2013;15:517-525. [PMID: 24101366 DOI: 10.1007/s11912-013-0341-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
14 Lahner E, Carabotti M, Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J Gastroenterol 2018; 24(22): 2373-2380 [PMID: 29904244 DOI: 10.3748/wjg.v24.i22.2373] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
15 Graham DY, Shiotani A, El-Zimaity HM. Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointest Endosc 2006;64:686-90. [PMID: 17055857 DOI: 10.1016/j.gie.2006.03.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
16 Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005;CD002096. [PMID: 15674892 DOI: 10.1002/14651858.cd002096.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
17 Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Review of Gastroenterology & Hepatology 2020;14:93-102. [DOI: 10.1080/17474124.2020.1718491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
18 Sun TT, Wang JL, Fang JY. Quality of RCTs exploring Helicobacter pylori eradication for the prevention of gastric cancer and preneoplastic lesions. Expert Rev Anticancer Ther 2011;11:1509-19. [PMID: 21999125 DOI: 10.1586/era.11.124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther. 2005;21:765-772. [PMID: 15771763 DOI: 10.1111/j.1365-2036.2005.02369.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
20 Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study: Randomised clinical trial: the impact of H. pylori eradication on BMI and weight. Alimentary Pharmacology & Therapeutics 2011;33:922-9. [DOI: 10.1111/j.1365-2036.2011.04610.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
21 Mini R, Annibale B, Lahner E, Bernardini G, Figura N, Santucci A. Western Blotting of Total Lysate of Helicobacter pylori in Cases of Atrophic Body Gastritis. Clinical Chemistry 2006;52:220-6. [DOI: 10.1373/clinchem.2005.054627] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
22 Kinoshita Y, Chiba T. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study. J Gastroenterol. 2012;47:377-386. [PMID: 22183857 DOI: 10.1007/s00535-011-0503-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
23 Lahner E, Conti L, Annibale B, Corleto VD. Current Perspectives in Atrophic Gastritis. Curr Gastroenterol Rep 2020;22:38. [PMID: 32542467 DOI: 10.1007/s11894-020-00775-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yoshioka T, Takeshita E, Sakata Y, Hara M, Akutagawa K, Sakata N, Endo H, Ohyama T, Matsunaga K, Tanaka Y, Shirai S, Ito Y, Tsuruoka N, Iwakiri R, Kusano M, Fujimoto K. Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups. Esophagus 2017;14:249-53. [PMID: 28725170 DOI: 10.1007/s10388-017-0573-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
25 de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol. 2009;104:1342-1345. [PMID: 19491846 DOI: 10.1038/ajg.2008.15] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
26 Moayyedi P, Soo S, Deeks JJ, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C. WITHDRAWN: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2011;CD002096. [PMID: 21328254 DOI: 10.1002/14651858.cd002096.pub5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
27 Xiang Z, Si JM, Huang HD. Chronic gastritis rat model and role of inducing factors. World J Gastroenterol 2004; 10(21): 3212-3214 [PMID: 15457578 DOI: 10.3748/wjg.v10.i21.3212] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
28 Ghoshal UC, Singh R, Chang FY, Hou X, Wong BC, Kachintorn U; Functional Dyspepsia Consensus Team of the Asian Neurogastroenterology and Motility Association and the Asian Pacific Association of Gastroenterology. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 2011;17:235-44. [PMID: 21860815 DOI: 10.5056/jnm.2011.17.3.235] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 7.5] [Reference Citation Analysis]
29 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 68] [Article Influence: 17.7] [Reference Citation Analysis]
30 Chen HN, Wang Z, Li X, Zhou ZG. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer. 2016;19:166-175. [PMID: 25609452 DOI: 10.1007/s10120-015-0462-7] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 12.9] [Reference Citation Analysis]
31 Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K; Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1-20. [PMID: 20302585 DOI: 10.1111/j.1523-5378.2009.00738.x] [Cited by in Crossref: 262] [Cited by in F6Publishing: 241] [Article Influence: 21.8] [Reference Citation Analysis]
32 Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83:253-260. [PMID: 21282951 DOI: 10.1159/000280318] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
33 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1744-1746 [DOI: 10.11569/wcjd.v12.i7.1744] [Reference Citation Analysis]
34 Kang HY, Kim SG, Lee MK, Kim JS, Jung HC, Song IS. Effect of Helicobacter pylori eradication according to the IL-8-251 polymorphism in Koreans. J Korean Med Sci 2012;27:1202-7. [PMID: 23091318 DOI: 10.3346/jkms.2012.27.10.1202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Cheung TK, Xia HH, Wong BC. Helicobacter pylori eradication for gastric cancer prevention. J Gastroenterol 2007;42 Suppl 17:10-5. [PMID: 17238019 DOI: 10.1007/s00535-006-1939-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
36 Suzuki H, Ataka K, Asakawa A, Cheng KC, Ushikai M, Iwai H, Yagi T, Arai T, Yahiro K, Yamamoto K, Yokoyama Y, Kojima M, Yada T, Hirayama T, Nakamura N, Inui A. Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice. Sci Rep 2019;9:6011. [PMID: 30979915 DOI: 10.1038/s41598-019-42163-4] [Reference Citation Analysis]
37 De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer: REVIEW: H. PYLORI ERADICATION FOR GASTRIC CANCER PREVENTION. Alimentary Pharmacology & Therapeutics 2007;26:25-35. [DOI: 10.1111/j.1365-2036.2007.03475.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
38 Kang JM, Kim N, Shin CM, Lee HS, Lee DH, Jung HC, Song IS. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. Helicobacter. 2012;17:86-95. [PMID: 22404438 DOI: 10.1111/j.1523-5378.2011.00918.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
39 Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005;37:39-43. [PMID: 15702858 DOI: 10.1016/j.dld.2004.07.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
40 Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A, Cesaro P, Lenti MV, Annibale B, Corazza GR. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis. 2019;51:1621-1632. [PMID: 31635944 DOI: 10.1016/j.dld.2019.09.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
41 Cheung TK, Wong BC. Treatment of Helicobacter pylori and prevention of gastric cancer. J Dig Dis. 2008;9:8-13. [PMID: 18251788 DOI: 10.1111/j.1443-9573.2007.00315.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
42 Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 2005;20:1652-60. [DOI: 10.1111/j.1440-1746.2005.04039.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
43 Yoon H. Atrophic Gastritis and Intestinal Metaplasia. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 515-20. [DOI: 10.1007/978-981-287-706-2_52] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 van Marrewijk CJ, van Oijen MG, Paloheimo LI, Fransen GA, Mujakovic S, Muris JW, Numans ME, De Wit NJ, Grobbee DE, Knottnerus JA, Laheij RJ, Jansen JB. Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsia. Aliment Pharmacol Ther 2009;30:82-9. [PMID: 19309389 DOI: 10.1111/j.1365-2036.2009.04001.x] [Reference Citation Analysis]
45 Torisu T, Matsumoto T, Takata Y, Ansai T, Soh I, Awano S, Nakamichi I, Kagiyama S, Sonoki K, Yoshida A. Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population. J Gastroenterol. 2008;43:762-766. [PMID: 18958544 DOI: 10.1007/s00535-008-2219-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]